In this article, we will discuss Pexidartinib and Patients with Renal Impairment. So, let’s get started.
Pexidartinib and Patients with Renal Impairment
Mild (CLcr 60 to 89 mL/min), moderate (CLcr 30 to 59 mL/min) and severe (CLcr 15 to
29 mL/min) renal impairment increased pexidartinib exposure (AUC) by approximately 30%, relative to that in patients with normal renal function (CLcr ≥90 mL/min).